Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Faldaprevir

Generic Name: Faldaprevir

Drug Type: Small Molecule

Chemical Formula: C_₄₀H_₄₉BrN_₆O_₉S

CAS Number: 801283-95-4

Unique Ingredient Identifier: 958X4J301A

Overview

Faldaprevir has been investigated for the treatment of Chronic Hepatitis C.

Background

Faldaprevir has been investigated for the treatment of Chronic Hepatitis C.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Faldaprevir, TD-6450 and Other Antivirals in Participants With Genotype 1b Hepatitis C Virus Infection

Phase 2

Completed

Posted: 2016/03/23

Sponsor:Trek Therapeutics, P...

ID:NCT02716428

A Study of Faldaprevir, Ribavirin and TD-6450 in Participants With Genotype 4 Hepatitis C Virus Infection

Phase 2

Completed

Posted: 2015/10/30

Sponsor:Trek Therapeutics, P...

ID:NCT02593162

Multiple Doses of BI 207127 NA, BI 201335 NA Followed by the Combination of BI 207127 NA and BI 201335 NA in Healthy Male Volunteers

Phase 1

Terminated

Posted: 2014/07/08

Sponsor:Boehringer Ingelheim

ID:NCT02182401

Safety, Tolerance, and Pharmacokinetics of Single Oral Doses of BI 201335 NA and Bioavailability in Healthy Male Subjects

Phase 1

Completed

Posted: 2014/07/08

Sponsor:Boehringer Ingelheim

ID:NCT02182323

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects

Phase 1

Completed

Posted: 2014/07/08

Sponsor:Boehringer Ingelheim

ID:NCT02182362

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy